一项新的血液测试通过测量与炎症和癌症有关的五种蛋白质,预测了5至10年的死亡率风险。 A new blood test predicts 5- to 10-year mortality risk by measuring five proteins linked to inflammation and cancer.

萨里大学研究人员开发的一项新的血液测试可能通过测量五种关键蛋白质 -- -- PLAUR、SERPINA3、CRIM1、DCP1和LTBP2 -- -- 与炎症、癌症和组织修补相关联,预测一个人在五至十年内死亡的风险。 A new blood test developed by University of Surrey researchers may predict an individual’s risk of dying within five to ten years by measuring levels of five key proteins—PLAUR, SERPINA3, CRIM1, DDR1, and LTBP2—linked to inflammation, cancer, and tissue repair. 科学家们分析了来自38 000多名英国生物银行参与者的数据,发现数百种与死亡风险有关的蛋白质,即使考虑到吸烟和先前的状况。 Analyzing data from over 38,000 UK Biobank participants, scientists found hundreds of proteins associated with mortality risk, even after accounting for smoking and pre-existing conditions. 这些结果公布在PLOS One上,表明测试可以及早发现高风险个人,支持及时采取医疗干预措施和提供个性化护理,尽管在临床使用前还需要进一步验证。 The results, published in PLoS One, suggest the test could enable early identification of high-risk individuals, supporting timely medical interventions and personalized care, though further validation is needed before clinical use.